Switzerland
Microsynth AG is a Swiss-based company, established in 1989, specializing in DNA and RNA synthesis, analysis, and contract research. The company operates in three key areas:
DNA/RNA Syntheses: Microsynth produces DNA and RNA oligonucleotides, primers, probes, and nucleotides for various research and diagnostic applications, including drug discovery and molecular diagnostics.
DNA/RNA Analyses and Sequencing: The company offers a wide range of analytical services, including DNA Sanger sequencing, next-generation sequencing, PCR, genotyping, and DNA/RNA isolations.
Contract Research/Outsourcing: Microsynth provides services such as assay establishment and validation, biological testing, and gene editing/gene therapy for pharmaceutical, biotech, and medical industries.
With over 100 employees and branch offices across Europe, Microsynth is ISO 9001:2015, ISO 13485:2016 and ISO/IEC 17025:2017 certified, as well as GMP certified for Sanger sequencing. The company prides itself on its commitment to scientific progress and environmental sustainability.